Keros Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $799k | 51k | 15.82 |
| 2025-06-30 | $692k | 52k | 13.35 |
| 2025-03-31 | $455k | 45k | 10.19 |
| 2024-12-31 | $647k | 41k | 15.83 |
| 2024-09-30 | $2.4M | 41k | 58.07 |
| 2024-06-30 | $1.9M | 42k | 45.70 |
| 2024-03-31 | $2.3M | 35k | 66.20 |
| 2023-12-31 | $1.3M | 32k | 39.76 |
| 2023-09-30 | $1.0M | 33k | 31.88 |
| 2023-06-30 | $1.3M | 33k | 40.18 |
| 2023-03-31 | $1.2M | 28k | 42.68 |
| 2022-12-31 | $1.3M | 26k | 48.02 |
| 2022-09-30 | $879k | 23k | 37.63 |
| 2022-06-30 | $560k | 20k | 27.65 |
| 2022-03-31 | $864k | 16k | 54.39 |
| 2021-12-31 | $813k | 14k | 58.48 |
| 2021-09-30 | $561k | 14k | 39.55 |
| 2021-06-30 | $574k | 14k | 42.50 |
| 2021-03-31 | $842k | 14k | 61.57 |
| 2020-12-31 | $960k | 14k | 70.53 |
| 2020-09-30 | $271k | 7.0k | 38.59 |
| 2020-06-30 | $294k | 7.8k | 37.53 |